Ivonescimab Monotherapy Decisively Beats Pembrolizumab Monotherapy Head-to-Head, Achieves Statistically Significant Superiority in PFS in First-Line Treatment of Patients with PD-L1 Positive NSCLC
Monotherapy Ivonescimab Achieved Clinically Meaningful PFS Benefit in HARMONi-2 Trial Conducted by Akeso PFS Improvement Was Observed Broadly in Patients Across Subgroups, including PD-L1 Low and PD-L1 High Expressing Tumors, Squamous and Non-Squamous Histologies Full Data Set to be Presented at an Upcoming Major Medical Conference Planned for Later This Year Unprecedented: Ivonescimab Is the First Drug...
SOPHiA GENETICS Launches Global Consortium, SOPHiA UNITY, to Accelerate Cancer Research, Drug Development, and Data-Driven Patient Care
New collective intelligence network to enable the most advanced research in oncology in support of precision medicine BOSTON and ROLLE, Switzerland, May 30, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced SOPHiA UNITY, a new data-driven consortium designed to...
TOOsonix receives MDR CE Mark for its new oncology and dermatology device
The EU Medical Device Regulation CE certification approves that the most common types of skin cancer and a wide range of skin diseases and conditions can be treated in less than 90 seconds. COPENHAGEN, Denmark, May 30, 2024 /PRNewswire/ -- TOOsonix A/S, a pioneer in high-intensity focused ultrasound (HIFU) technology for dermatology,...
Teikoku Pharma USA, Inc. Announces NMPA Approved Lidoderm® in China on May 8, 2024
SAN JOSE, Calif., May 30, 2024 /PRNewswire/ -- Teikoku Pharma USA (TPU) announced today that the NMPA (National Medical Products Administration) has approved Lidoderm® ("lidocaine 5% patch as lidocaine cataplasms") for the treatment of Post Herpetic Neuralgia (PHN) in China. TPU entered into an exclusive licensing agreement with Link Healthcare Group...
Vatech Enhances AI in Dental Diagnostic Solutions
SEOUL, South Korea, May 30, 2024 /PRNewswire/ -- Vatech, a leading player in the dental medical device sector, is embarking on the development and implementation of various AI technologies to aid in dental diagnosis. Example of using AI to estimate clinically relevant anatomical clinical structures(left), AI 3D...
OBiO Technology Officially Launched the Center for Clinical Evaluation and Translation of Advanced Therapies for Pediatric Rare and Genetic Diseases
SHANGHAI, May 30, 2024 /PRNewswire/ -- On May 23, OBiO Technology, a world leading contract development and manufacturing organization for cell and gene therapy, officially launched the "Center for Clinical Evaluation and Translation of Advanced Therapies for Pediatric Rare and Genetic Diseases" (hereinafter referred to as the "Clinical Evaluation and Translation Center")...
ZEISS announces OCT technology enhancements to better support growing era of data-driven patient care
ZEISS Medical Ecosystem fortifies the CIRRUS 6000 with the U.S. market's largest OCT reference database and advanced cybersecurity features. DUBLIN, Calif., May 30, 2024 /PRNewswire/ -- ZEISS Medical Technology announced today that the CIRRUS® 6000 from ZEISS now enables a highly efficient and data-driven workflow for ophthalmologists, supported by the largest OCT (optical...
Metabolon Announces 4-Week Turnaround Time for Commercial Projects, Enhancing Metabolomic Services for Multiomic Research
MORRISVILLE, N.C., May 30, 2024 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, today announced a significant enhancement to its services with a new 4-week project turnaround time for Global Discovery Panel projects...
Illusion Aligners Makes Record-Breaking Achievement with its Biggest Aligner in India
MUMBAI, India, May 30, 2024 /PRNewswire/ -- In India's vibrant Dental fraternity, Illusion Aligners stands out as a trusted manufacturer of Clear Aligners. Renowned for its commitment to excellence and utilization of state-of-the-art technology, the brand has earned widespread recognition among both Indian and global Dental Professionals. But their latest endeavour transcends their previous achievements. Breaking new ground in...
Preliminary Clinical Data on Relma-Cel Injection in Adults with Active Systemic Lupus Erythematosus in China at the Eular 2024 Congress
SHANGHAI, May 30, 2024 /PRNewswire/ -- JW (Cayman) Therapeutics Co. Ltd (the "Company" or "JW Therapeutics", together with its subsidiaries, the "Group"), an independent and innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy products, presented the preliminary clinical data on relmacabtagene autoleucel ("relma-cel") injection in adults with active systemic lupus erythematosus ("SLE") in China at the 2024...
